CN101856323A - 一种含林蛙抗菌肽的β-CD包合物栓剂及其制备方法 - Google Patents
一种含林蛙抗菌肽的β-CD包合物栓剂及其制备方法 Download PDFInfo
- Publication number
- CN101856323A CN101856323A CN 201010200884 CN201010200884A CN101856323A CN 101856323 A CN101856323 A CN 101856323A CN 201010200884 CN201010200884 CN 201010200884 CN 201010200884 A CN201010200884 A CN 201010200884A CN 101856323 A CN101856323 A CN 101856323A
- Authority
- CN
- China
- Prior art keywords
- suppository
- preparation
- beta
- wood frog
- inclusion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 title claims abstract description 33
- 239000000829 suppository Substances 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 239000003910 polypeptide antibiotic agent Substances 0.000 title claims abstract description 7
- 241001336827 Rana chensinensis Species 0.000 title abstract 2
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims abstract description 3
- 241000191896 Rana sylvatica Species 0.000 claims description 38
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 37
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 37
- 230000003115 biocidal effect Effects 0.000 claims description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 9
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 8
- 229930195729 fatty acid Natural products 0.000 claims description 8
- 239000000194 fatty acid Substances 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 6
- 239000000758 substrate Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 4
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 4
- 244000299461 Theobroma cacao Species 0.000 claims description 4
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 claims description 4
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 claims description 4
- 238000013019 agitation Methods 0.000 claims description 4
- 235000001046 cacaotero Nutrition 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 238000001704 evaporation Methods 0.000 claims description 4
- -1 fatty acid ester Chemical class 0.000 claims description 4
- 239000000314 lubricant Substances 0.000 claims description 4
- 239000011159 matrix material Substances 0.000 claims description 4
- 238000002844 melting Methods 0.000 claims description 4
- 230000008018 melting Effects 0.000 claims description 4
- 235000011837 pasties Nutrition 0.000 claims description 4
- 238000013138 pruning Methods 0.000 claims description 4
- 239000003229 sclerosing agent Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 235000021355 Stearic acid Nutrition 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
- 239000008117 stearic acid Substances 0.000 claims description 3
- 235000013869 carnauba wax Nutrition 0.000 claims description 2
- 239000004203 carnauba wax Substances 0.000 claims description 2
- 239000007765 cera alba Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 239000000470 constituent Substances 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 10
- 201000010099 disease Diseases 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 9
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 8
- 238000002474 experimental method Methods 0.000 abstract description 5
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- 241000222122 Candida albicans Species 0.000 abstract description 2
- 241000191967 Staphylococcus aureus Species 0.000 abstract description 2
- 229940095731 candida albicans Drugs 0.000 abstract description 2
- 206010059866 Drug resistance Diseases 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 17
- 239000000243 solution Substances 0.000 description 14
- 210000001215 vagina Anatomy 0.000 description 9
- 239000006228 supernatant Substances 0.000 description 6
- 239000002552 dosage form Substances 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 4
- 239000000825 pharmaceutical preparation Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000725303 Human immunodeficiency virus Species 0.000 description 3
- 206010042566 Superinfection Diseases 0.000 description 3
- 206010046914 Vaginal infection Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 201000008100 Vaginitis Diseases 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000000452 restraining effect Effects 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241001033779 Eurytoma orchidearum Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 229960002152 chlorhexidine acetate Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000005224 forefinger Anatomy 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000002511 suppository base Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102008847A CN101856323B (zh) | 2010-06-11 | 2010-06-11 | 一种含林蛙抗菌肽的β-CD包合物栓剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102008847A CN101856323B (zh) | 2010-06-11 | 2010-06-11 | 一种含林蛙抗菌肽的β-CD包合物栓剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101856323A true CN101856323A (zh) | 2010-10-13 |
CN101856323B CN101856323B (zh) | 2011-11-09 |
Family
ID=42942628
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102008847A Active CN101856323B (zh) | 2010-06-11 | 2010-06-11 | 一种含林蛙抗菌肽的β-CD包合物栓剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101856323B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108498876A (zh) * | 2018-05-06 | 2018-09-07 | 李志军 | 抑菌润滑凝胶 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1216768A (zh) * | 1998-10-29 | 1999-05-19 | 吉林大学 | 生物抗菌肽及其制备方法 |
CN1583165A (zh) * | 2004-05-25 | 2005-02-23 | 吉林大学 | 林蛙抗菌肽凝胶剂及其制备方法 |
CN101418039A (zh) * | 2008-12-10 | 2009-04-29 | 辽宁师范大学 | 一种新的抗菌肽及其制备方法和应用 |
CN101456910A (zh) * | 2008-11-14 | 2009-06-17 | 吉林大学 | 林蛙抗菌肽及制备工艺和在抗病毒药物中的应用 |
-
2010
- 2010-06-11 CN CN2010102008847A patent/CN101856323B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1216768A (zh) * | 1998-10-29 | 1999-05-19 | 吉林大学 | 生物抗菌肽及其制备方法 |
CN1583165A (zh) * | 2004-05-25 | 2005-02-23 | 吉林大学 | 林蛙抗菌肽凝胶剂及其制备方法 |
CN101456910A (zh) * | 2008-11-14 | 2009-06-17 | 吉林大学 | 林蛙抗菌肽及制备工艺和在抗病毒药物中的应用 |
CN101418039A (zh) * | 2008-12-10 | 2009-04-29 | 辽宁师范大学 | 一种新的抗菌肽及其制备方法和应用 |
Non-Patent Citations (2)
Title |
---|
《中国药学杂志》 20061130 田晓乐,等 林蛙抗菌肽喷雾剂的制备及体外抑菌活性研究 1635-1638 第41卷, 第21期 2 * |
《高等学校化学学报》 20070630 周杰,等 一种中国林蛙抗菌肽的光谱研究 1064-1068 第28卷, 第6期 2 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108498876A (zh) * | 2018-05-06 | 2018-09-07 | 李志军 | 抑菌润滑凝胶 |
Also Published As
Publication number | Publication date |
---|---|
CN101856323B (zh) | 2011-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Singh et al. | Oral mucositis | |
US20130108599A1 (en) | Herbal Vaginal Compositions | |
US5837254A (en) | Method of treating candida and cryptococcus fungal infections by administering gentian | |
CN111803624A (zh) | 一种含有转移因子的皮肤抗菌凝胶制剂和制备方法 | |
US20060222722A1 (en) | Sublingual methods of treatment to alleviate or prevent arthritis | |
US20200330543A1 (en) | A topical herbal healing formulation | |
CN101856323B (zh) | 一种含林蛙抗菌肽的β-CD包合物栓剂及其制备方法 | |
CN110664858B (zh) | 一种用于皮肤的青蒿提取物组合物、产品及其应用 | |
CN104338147A (zh) | 一种用于缓控释给药的软膏组合基质 | |
CN103520262B (zh) | 一种脂溶性妇科凝胶 | |
CN103655735B (zh) | 一种治疗脚气、皮肤瘙痒症泡洗剂 | |
CN102920656A (zh) | 一种莫西沙星纳米乳及其制备方法 | |
CN111973656B (zh) | 一种含有抑菌促愈合组合物的口腔溃疡制剂 | |
CN108904591A (zh) | 一种安全高效消肿止痒剂及其制备方法 | |
CN109464655B (zh) | 一种防治阴道炎的外用胶囊制剂 | |
CN113616774A (zh) | 一种含植物干细胞的抑菌组合物、养护抑菌液及其制备方法 | |
CN112022851A (zh) | 氯喹的新用途 | |
CN103520204B (zh) | 一种含氯诺昔康和聚维酮碘的药物组合物 | |
CN107583050A (zh) | 一种用于治疗宫颈炎的药物组合物及用途 | |
Hossain | Preparation and Characterisation of Alginate-Based Honey-Loaded Topical Formulations | |
US11565020B2 (en) | Powdered collagen wound care compositions | |
CN100387254C (zh) | 一种中药栓剂及其制备方法 | |
CN107080817A (zh) | 一种新型妇科千金莪术油栓 | |
CN100584364C (zh) | 一种活血壮筋胶囊及其制备工艺 | |
CN107613773A (zh) | 用于治疗或预防组织感染和疾病的纳米颗粒组合物和方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210806 Address after: 130000 No. 2266, Jingkai Ring Road, Tonghua Development Zone, Tonghua City, Jilin Province Patentee after: TONGHUA KANG YUAN BIOLOGICAL TECHNOLOGY Co.,Ltd. Address before: 130012 No. 2699 Qianjin Street, Jilin, Changchun Patentee before: Jilin University |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Kind of Antibacterial Peptide Containing Forest Frog b- CD inclusion complex suppository and its preparation method Effective date of registration: 20230324 Granted publication date: 20111109 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: TONGHUA KANG YUAN BIOLOGICAL TECHNOLOGY Co.,Ltd. Registration number: Y2023220000019 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20111109 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: TONGHUA KANG YUAN BIOLOGICAL TECHNOLOGY Co.,Ltd. Registration number: Y2023220000019 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A forest frog antimicrobial peptide containing b- CD inclusion complex suppository and its preparation method Granted publication date: 20111109 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: TONGHUA KANG YUAN BIOLOGICAL TECHNOLOGY Co.,Ltd. Registration number: Y2024220000023 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |